Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Esophagus
Published in: Esophagus 2/2006

01-07-2006 | ORIGINAL ARTICLE

Predictive factors for lymph node metastasis in esophageal squamous cell carcinomas contacting or penetrating the muscularis mucosae: the utility of droplet infiltration

Authors: Hideto Egashira, Akio Yanagisawa, Yo Kato

Published in: Esophagus | Issue 2/2006

Login to get access
Metadata
Title
Predictive factors for lymph node metastasis in esophageal squamous cell carcinomas contacting or penetrating the muscularis mucosae: the utility of droplet infiltration
Authors
Hideto Egashira
Akio Yanagisawa
Yo Kato
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Esophagus / Issue 2/2006
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-006-0074-8

Other articles of this Issue 2/2006

Esophagus 2/2006 Go to the issue

ORIGINAL ARTICLE

Evaluation of the quality of life after surgical treatment for thoracic esophageal cancer

CASE REPORT

Esophageal small cell carcinoma effectively treated by cisplatin and irinotecan

CASE ATLAS

Superficial squamous cell carcinoma of the esophagus type 0-IIa (m3)

ORIGINAL ARTICLE

Individualization of lymphadenectomy in superficial esophageal squamous cell cancer

CASE REPORT

A case of severe chylothorax after esophagectomy successfully treated by a new combination of continuous positive-pressure ventilation plus chemical pleurodesis

CASE REPORT

Giant fibrovascular polyp of the esophagus: MRI is useful for diagnosis and surgical planning
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits